Human rotavirus vaccine (RIX4414) efficacy in the first two years of life: A randomized, placebo-controlled trial in China

Rotaviruses (RV) are a major cause of severe gastroenteritis (GE) in children aged <5 y. For the first time in China, we assessed the efficacy of two oral doses of the human rotavirus vaccine (RIX4414) in infants during the first two years of life (113808/NCT01171963). Healthy infants aged 6–16 w...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Li, Rong-cheng, Huang, Teng, Li, Yan-Ping, Luo, Dong, Tao, Junhui, Fu, Botao, Si, Guoai, Nong, Yi, Mo, Zhao-Jun, Liao, Xue-Yan, Luan, Ivy, Tang, Haiwen, Rathi, Niraj, Karkada, Naveen, Han, Htay Htay
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Landes Bioscience 2014
Gaiak:
Research Paper
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4181005/
https://ncbi.nlm.nih.gov/pubmed/24013441
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/hv.26319
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak